ESC Congress 2025

Richmond Pharmacology is pleased to announce our attendance at ESC Congress 2025, the European Society of Cardiology’s flagship event, held in Madrid from 29^thAugust– 1^st September.

Representing Richmond Pharmacology at ESC Congress:

• Dr Jörg Täubel, Chief Executive Officer

DrTäubel looks forward to connecting with clinicians, researchers, and industryleaders, sharing Richmond’s expertise in:

• Early-phase cardiovascular and cardiometabolic trials
• Novel endpoints and digital health integration
• Risk-stratified study design and cardiac safety
• Accelerated CV drug development pathways
• Patient-focused recruitment and retention

If you’re attending ESC 2025 and seeking an expert partner for cardiovascular clinical trials, we welcome meeting requests at: info@richmondpharmacology.com

Learn more: ESC2025 | ESC 2025 Registration | ESC Annual Congress 2025

‍